20/20 Biolabs reduces stockholder meeting quorum from majority to one-third

20/20 Biolabs, Inc.

Board adopted Amendment No. 1 to Bylaws on May 19, 2026.
Quorum required for stockholder meetings reduced from majority to one-third of outstanding shares.
Amendment to Section 2.5 of Amended and Restated Bylaws; effective immediately.
No other changes to stockholder rights or company governance structure.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

20/20 Biolabs, Inc.: Reduced the quorum required for a meeting of stockholders from a majority of the shares outstanding to one-third of the shares outstanding (effective 2026-05-19).

Change: bylaw amendment
Effective: 2026-05-19

Exact text from the filing

On May 19, 2026, the Board of Directors of 20/20 Biolabs, Inc. (the “ Company ”) adopted Amendment No. 1 to the Company’s Amended and Restated Bylaws (the “ Amendment ”), pursuant to which Section 2.5 of the Company’s Amended and Restated Bylaws was amended to reduce the quorum required for a meeting of stockholders from a majority of the shares outstanding to one-third of the shares outstanding.

View on SEC.gov

Browse all governance changes →

20/20 Biolabs, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-061039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.